Hologic, Inc.: Hologic to Acquire Mobidiag, Innovator in Near-Patient, Acute Care Diagnostic Testing, for Approximately $795 Million
(0) -- Transaction Will Accelerate Global Growth of Mobidiag's Differentiated Molecular Platform, which Offers Ease of Use, Multiplex Capability and Rapid Turnaround Time -- Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has signed a definitive agreement to acquire Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular diagnostic tests and instrumentation, for an enterprise value of approximately $795 million. This includes a cash payment of approximately $714 million (€600 million) for Mobidiag's equity, an...
Source: finanznachrichten.de